View Financial HealthReflect Scientific 배당 및 자사주 매입배당 기준 점검 0/6Reflect Scientific 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률n/a자사주 매입 수익률총 주주 수익률n/a미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • May 20Reflect Scientific Strengthens Position in Booming AI Data Center Cooling Market with Patented Cryogenic InnovationsReflect Scientific, Inc. highlighted how its patented solutions are uniquely positioned to address the growing global demand for advanced data center cooling, driven by the explosive growth of AI and hyperscale computing. The global data center cooling market is expected to reach $42-56 billion by 2030, expanding at a double-digit annual growth rate. Soaring compute demands from AI workloads, tightening sustainability regulations, and expanding hyperscale facilities force data center operators to rethink traditional cooling methods. Reflect's patented cryogenic cooling technologies directly target these emerging needs by offering ultra-efficient, low-temperature solutions designed for high-density AI environments. Reflect's innovations are especially timely as data centers now consume roughly 1-2% of global electricity, with projections that AI-dedicated centers could more than double their energy use by 2026. Major industry players are making bold moves to meet this challenge. For example, Samsung Electronics recently acquired cooling manufacturer FlaktGroup for $1.7 billion to strengthen its AI data center cooling position. This strategic activity highlights the urgent global demand for advanced cooling solutions, where Reflect Scientific's cryogenic technologies offer a differentiated and potentially disruptive answer. Cryogenic cooling is emerging as the next frontier for extreme-density computing, with research showing that cooling chips to cryogenic temperatures can double their efficiency. Major players, including academic institutions and hyperscale operators, are already exploring sub-zero cooling technologies for specialized AI and quantum computing deployments -- markets where Reflect Scientific's expertise and patents place it at the forefront. Reflect Scientific's patented technologies complement other advances in the sector, such as the rapid adoption of liquid cooling and immersion cooling, but offer advantages for the most thermally intensive AI "factories" of the future.공시 • May 14Reflect Scientific Secures Patents for Data Center Cooling with Cryogenic InnovationReflect Scientific, Inc. announced a U.S. Patent for its innovative system to cool computer rooms using cryogenic methods. This development addresses the growing challenge of heat management in data centers and server farms, especially as artificial intelligence and cloud computing dramatically increase computing loads and energy consumption. The patented "Room Portable Blast Chiller" introduces a fast-response, energy-efficient system that uses liquid nitrogen to rapidly cool overheated spaces in IT environments. It is instrumental during power surges, peak usage times, or brownout conditions threatening sensitive computing hardware. Key features of the new system include: A compact, portable blast chiller that can reduce a room's temperature in minutes--no external electrical connection required. A patented heat exchanger design that delivers rapid cooling without flow restrictions. A version mountable to a wall for fixed installations, ideal for permanent server room integration. This advancement reinforces Reflect Scientific's commitment to cutting-edge cryogenic systems that serve the biotechnology, pharmaceutical, and IT infrastructure sectors.공시 • Mar 15Reflect Scientific, Inc. Files Form 15Reflect Scientific, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Common stock under the Securities Exchange Act of 1934, as amended. The par value of the company's Common stock was $0.01 per share.공시 • Oct 25Reflect Scientific Inc. Announces Successful Testing of Liquid Nitrogen Temperature Control TechnologyReflect Scientific, Inc. announced the successful testing of its liquid nitrogen temperature control technology, offering a promising alternative to hydrofluorocarbon (HFC) refrigerants in building air conditioning systems. The Environmental Protection Agency's increased restrictions on using HFCs – potent greenhouse gases found in standard refrigerators and air conditioning systems – have propelled the search for sustainable alternatives. In response, RSI, having recently secured a patent for using liquid nitrogen or liquid air in cooling systems, undertook intensive testing to validate its effectiveness as a substitute for HFCs. Results conclusively demonstrated the technology's capability to accurately and reliably control temperatures across residential and industrial applications. Having already established a reputation for its ultra-low temperature freezer and chiller products in sectors including Pharmaceutical, Biotechnology, and Nutraceuticals, RSI has been at the forefront of eliminating the need for HFCs. With this latest development, the Company expands its reach, introducing its patented technology to broader sectors. This effort encompasses cold chain management fields like Reefer transportation trucks and air freight containers, Cryostats, and the recent focus on residential and commercial refrigeration and air conditioning.공시 • Jul 20California Air Resources Board Recent Amendments to the Airborne Toxic Control Measure for Reefer Transportation Units Favors Reflect Scientific’s Cryogenic Clean Air Reefer’SReflect Scientific, Inc. announced the California Air Resources Board has recently amended California’s regulations to favor the Cryometrix CB 40 cold transportation trailer opening the door to adoption. Transport refrigeration trailers (aka Reefers) emit multiple air pollutants, including diesel particulate matter, fine particulate matter, oxides of nitrogen, and greenhouse gases. Reefers typically operate at refrigerated warehouses or distribution centers, grocery stores, seaport facilities, and intermodal railyards and are used for the temperature-controlled transportation of perishable goods. Refrigerated trucks haul over 90 percent of the food Americans eat, and there are more than 500,000 refrigerated trailers in service in the United States. Key elements of the amendment include the use of a lower global warming potential refrigerant and more stringent particulate emission standards. These elements can be addressed with the Cryometrix CB 40 system, which utilizes a proven and patented liquid nitrogen temperature control technology, avoiding the need for diesel-driven compressor units that employ HFC-type refrigerants.공시 • Feb 10Reflect Scientific, Inc. Announces Continue Strong Orders with an Additional $231,000 in Cryometrix Brand Ultra-Low Temperature FreezersReflect Scientific, Inc. announced continued strong orders with an additional $231,000 in Cryometrix brand ultra-low temperature freezers. The Cryometrix line of ultra-low temperature freezers uses patented liquid nitrogen cooling technology to achieve cooling rates and system reliability far exceeding current freezer technologies. The Cryometrix ultra-low temperature freezers are available from a 120 liter chest to a front opening unit with 950 liters of capacity.공시 • Feb 02Reflect Scientific, Inc. Announces New Ultra-Low Temperature Freezer Addition to the CryometrixReflect Scientific, Inc. announced a new ultra-low temperature freezer addition to the Cryometrix product line that can be rapidly deployed in a transportable, self-powered configuration. The new Cryometrix RDC-120 freezer is sized explicitly for storing smaller quantities of vaccines and high-value biologicals. Designed with the same patented liquid nitrogen cooling technology as the very successful larger freezers, the RDC-120 can be installed at a fixed site or configured for entirely self-contained operation. This versatility makes it ideal for field deployment, temporary or permanent cold storage, or a transportable low-temperature storage unit. The internal storage capacity is approximately 120 liters and has a temperature storage range of 0C to -160C. Cooldown from room temperature to -80C takes a short 5 minutes. Return to a set temperature of -80C after door opening is a speedy 2 minutes protecting valuable payloads such as the Pfizer COVID vaccine from damaging temperature swings.공시 • Jan 14Reflect Scientific Inc Receives Sales Contract for Cryometrix FreezersReflect Scientific, Inc. announced a $416K sales contract for Cryometrix B-90 blast freezers from a prominent pharmaceutical company. A significant $416K order has been placed for Cryometrix B-90 blast freezers destined to ship to the US and the British Isles. The Cryometrix B-90 blast freezer is an ultra-cold refrigeration product that can rapidly cool the payload bay from +20C (68F) to -80C (-130F) in 7 minutes. The freezer technology covered under several patents uses a closed liquid nitrogen system keeping the liquid nitrogen from contact with the payload and personnel. The B-90 freezer is used in the process of creating and storing the newest biopharmaceuticals and mRNA vaccines.공시 • Dec 16Reflect Scientific Inc. Adds Another Low Temperature Refrigeration Patent Solution to Its Growing Intellectual Property Portfolio, and Business UpdateReflect Scientific, Inc. announced that an additional patent has been granted by United States Patent Office for an ultra-low temperature (-160C) chest freezer based on the proven Cryometrix liquid nitrogen cooling technology. Ultra-low temperature mechanical freezers face unique issues. Lack of temperature uniformity throughout the storage volume can be a problem for both upright and chest freezers. Opening and closing the door creates a large influx of warm air causing an extended temperature recovery time. Reflect Scientific has already addressed this concern for upright freezers with its unique liquid nitrogen based Cryometrix system. A recently issued Reflect Scientific patent now addresses these concerns with a superior chest freezer design. The Cryometrix chest freezer temperature stability and resistance to warm air infiltration during opening provides a very consistent, controlled low temperature environment that can be relied upon for safely storing high value products such as CAR-T therapeutics. This patented technology provides the next level of temperature uniformity and control. The cold chain management of COVID vaccines continues to present challenges in storage and distribution; and believe patented freezer technology could have a favorable and positive impact on the current pandemic and would be a valuable asset for the distribution and storage of the current COVID-19 vaccines that require storage at extremely cold temperatures. On sales front, have several freezer systems scheduled for shipment this year, with a number of other orders anticipated in the first quarter of 2021 from multiple worldwide pharmaceutical companies; are pleased with the level of activity are seeing, and remain optimistic that the Company may realize positive earnings per share for 2020. The Company is presently debt free. In the area of cold chain management, are continuing discussions with a major supplier of air transport containers regarding the integration of liquid nitrogen systems to enable cooling and temperature control of sensitive payloads. Company are still awaiting response from Operation Warp Speed, a FEMA contractor, and other organizations, from who have received inquiries for Cryometrix S-90 cryogenic shipping and storage system. These systems can also serve as a cold (e.g. -80C) storage unit once at destination. do have a large-scale manufacturing capability should these inquires firm up. In terms of the competitive advantages of products, believe the Cryometrix liquid nitrogen freezers offer the following principal benefits versus mechanically driven ULT's or the utilization of dry ice. They can: (i) accommodate a wide range of temperature storage conditions (i.e. anywhere from room temperature to as low as -90C); (ii) have a very rapid temperature recovery from door openings, making it safer, for example, in maintaining COVID vaccines at the desired critical temperature; and (iii) the Cryometrix liquid nitrogen system has a very high operational reliability, keeping potential waste of valuable payloads to essentially zero compared to mechanically driven freezers that can be susceptible to failure. Company do not require dry ice, which has temperature limitations. Dry ice is limited to -78.5C (the current Pfizer vaccine has been reported to require -80C); and dry ice can also present challenges with respect to handling. On the other hand, liquid nitrogen in the Cryometrix system is in a contained environment. Cryometrix freezers typically show higher storage capacity per footprint compared to mechanical freezers, and they have excellent temperature uniformity throughout the payload space with essentially no build-up of ice on payload. The newly granted patent for a “chest” freezer will be a welcome and important addition to Cryometrix freezers.공시 • Dec 03Reflect Scientific, Inc. Announces A Patent Has Been Granted by the United States Patent Office for an Ultracold Shipping and Storage Container for Transportation by Air That Uses Liquid Nitrogen Technology for CoolingReflect Scientific, Inc. announced a patent has been granted by the United States Patent Office for an ultracold shipping and storage container for transportation by air that uses liquid nitrogen technology for cooling. The large shipping system could carry many thousands of doses of vaccines and utilizes the commercially proven Cryometrix patented cooling and freezing technology that has the flexibility to provide precise temperature control across a wide range of temperatures. The system accommodates payloads ranging from those requiring conventional refrigeration to specialty products such as COVID-19 and related vaccines that may require temperatures as low as -80° centigrade (-112° Fahrenheit). Systems can be configured to provide for short or long duration shipping cycles, making it an ideal choice for cold chain management.공시 • Oct 13Reflect Scientific, Inc. Introduces Cryometrix Electric Powered Heavy-Duty Trucks for Pollution Free Shipping of COVID-19 VaccinesReflect Scientific, Inc. announced with several companies working towards introducing electric powered heavy-duty trucks, the Cryometrix 53-foot reefer trailer is ideally positioned to complete an all green package that replaces the diesel-powered tractor-trailers that are currently in use for transportation of goods requiring controlled temperatures. The Cryometrix technology offers a reliable, pollution-free system with a flexible wide-ranging temperature setpoint control that can be adjusted to match payload requirements. This single system approach could be an essential consideration when selecting a transportation means for shipping biologics such as COVID-19 vaccines. The Cryometrix CB-40 TRU is a pollution free refrigeration alternative to diesel-powered systems for transport trailers. The CB-40 uses a patented self-contained liquid nitrogen cooling system to achieve consistent temperature control with almost no moving parts, no noise and superior reliability. A closed, self-contained refrigeration system ensures nothing but fresh cold air enters the trailer. The system is a direct replacement for current diesel systems and is easily retrofitted into an existing trailer. Not only is there no diesel engine, there is also no compressor. Fewer moving parts contribute to a significantly reduced maintenance requirement. System weight is comparable to diesel systems. The Cryometrix system was proven in demonstration runs from Salt Lake City to Los Angeles and Denver. A challenging first test -- to maintain refrigeration in a 53-foot trailer filled with perishable goods traveling round trip from Salt Lake City, UT to Los Angeles, CA. The unit performed beyond expectations. The goods were delivered with no loss and no significant problems with the system. The 1323 mile road test proved successful. The second successful test involved the transportation of frozen foodstuffs to Denver. Frozen ravioli, lasagna, corn dogs, and for desert ice cream and popsicles were all loaded into a 53-foot trailer in Salt Lake City. Exactly 525 miles, seven stops and 24 hours later, the trailer, now empty, sat quietly in Denver, still maintaining the temperature at -15 F. This was a tough test for the system as maintaining products frozen at -15 F is challenging, the outside air temperature was varying and there were multiple stops where cargo was unloaded.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 RSCF 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: RSCF 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Reflect Scientific 배당 수익률 vs 시장RSCF의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (RSCF)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.3%업계 평균 (Life Sciences)0.7%분석가 예측 (RSCF) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 RSCF 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 RSCF 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 RSCF 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: RSCF 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 01:32종가2026/05/20 00:00수익2024/09/30연간 수익2023/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Reflect Scientific, Inc.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • May 20Reflect Scientific Strengthens Position in Booming AI Data Center Cooling Market with Patented Cryogenic InnovationsReflect Scientific, Inc. highlighted how its patented solutions are uniquely positioned to address the growing global demand for advanced data center cooling, driven by the explosive growth of AI and hyperscale computing. The global data center cooling market is expected to reach $42-56 billion by 2030, expanding at a double-digit annual growth rate. Soaring compute demands from AI workloads, tightening sustainability regulations, and expanding hyperscale facilities force data center operators to rethink traditional cooling methods. Reflect's patented cryogenic cooling technologies directly target these emerging needs by offering ultra-efficient, low-temperature solutions designed for high-density AI environments. Reflect's innovations are especially timely as data centers now consume roughly 1-2% of global electricity, with projections that AI-dedicated centers could more than double their energy use by 2026. Major industry players are making bold moves to meet this challenge. For example, Samsung Electronics recently acquired cooling manufacturer FlaktGroup for $1.7 billion to strengthen its AI data center cooling position. This strategic activity highlights the urgent global demand for advanced cooling solutions, where Reflect Scientific's cryogenic technologies offer a differentiated and potentially disruptive answer. Cryogenic cooling is emerging as the next frontier for extreme-density computing, with research showing that cooling chips to cryogenic temperatures can double their efficiency. Major players, including academic institutions and hyperscale operators, are already exploring sub-zero cooling technologies for specialized AI and quantum computing deployments -- markets where Reflect Scientific's expertise and patents place it at the forefront. Reflect Scientific's patented technologies complement other advances in the sector, such as the rapid adoption of liquid cooling and immersion cooling, but offer advantages for the most thermally intensive AI "factories" of the future.
공시 • May 14Reflect Scientific Secures Patents for Data Center Cooling with Cryogenic InnovationReflect Scientific, Inc. announced a U.S. Patent for its innovative system to cool computer rooms using cryogenic methods. This development addresses the growing challenge of heat management in data centers and server farms, especially as artificial intelligence and cloud computing dramatically increase computing loads and energy consumption. The patented "Room Portable Blast Chiller" introduces a fast-response, energy-efficient system that uses liquid nitrogen to rapidly cool overheated spaces in IT environments. It is instrumental during power surges, peak usage times, or brownout conditions threatening sensitive computing hardware. Key features of the new system include: A compact, portable blast chiller that can reduce a room's temperature in minutes--no external electrical connection required. A patented heat exchanger design that delivers rapid cooling without flow restrictions. A version mountable to a wall for fixed installations, ideal for permanent server room integration. This advancement reinforces Reflect Scientific's commitment to cutting-edge cryogenic systems that serve the biotechnology, pharmaceutical, and IT infrastructure sectors.
공시 • Mar 15Reflect Scientific, Inc. Files Form 15Reflect Scientific, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its Common stock under the Securities Exchange Act of 1934, as amended. The par value of the company's Common stock was $0.01 per share.
공시 • Oct 25Reflect Scientific Inc. Announces Successful Testing of Liquid Nitrogen Temperature Control TechnologyReflect Scientific, Inc. announced the successful testing of its liquid nitrogen temperature control technology, offering a promising alternative to hydrofluorocarbon (HFC) refrigerants in building air conditioning systems. The Environmental Protection Agency's increased restrictions on using HFCs – potent greenhouse gases found in standard refrigerators and air conditioning systems – have propelled the search for sustainable alternatives. In response, RSI, having recently secured a patent for using liquid nitrogen or liquid air in cooling systems, undertook intensive testing to validate its effectiveness as a substitute for HFCs. Results conclusively demonstrated the technology's capability to accurately and reliably control temperatures across residential and industrial applications. Having already established a reputation for its ultra-low temperature freezer and chiller products in sectors including Pharmaceutical, Biotechnology, and Nutraceuticals, RSI has been at the forefront of eliminating the need for HFCs. With this latest development, the Company expands its reach, introducing its patented technology to broader sectors. This effort encompasses cold chain management fields like Reefer transportation trucks and air freight containers, Cryostats, and the recent focus on residential and commercial refrigeration and air conditioning.
공시 • Jul 20California Air Resources Board Recent Amendments to the Airborne Toxic Control Measure for Reefer Transportation Units Favors Reflect Scientific’s Cryogenic Clean Air Reefer’SReflect Scientific, Inc. announced the California Air Resources Board has recently amended California’s regulations to favor the Cryometrix CB 40 cold transportation trailer opening the door to adoption. Transport refrigeration trailers (aka Reefers) emit multiple air pollutants, including diesel particulate matter, fine particulate matter, oxides of nitrogen, and greenhouse gases. Reefers typically operate at refrigerated warehouses or distribution centers, grocery stores, seaport facilities, and intermodal railyards and are used for the temperature-controlled transportation of perishable goods. Refrigerated trucks haul over 90 percent of the food Americans eat, and there are more than 500,000 refrigerated trailers in service in the United States. Key elements of the amendment include the use of a lower global warming potential refrigerant and more stringent particulate emission standards. These elements can be addressed with the Cryometrix CB 40 system, which utilizes a proven and patented liquid nitrogen temperature control technology, avoiding the need for diesel-driven compressor units that employ HFC-type refrigerants.
공시 • Feb 10Reflect Scientific, Inc. Announces Continue Strong Orders with an Additional $231,000 in Cryometrix Brand Ultra-Low Temperature FreezersReflect Scientific, Inc. announced continued strong orders with an additional $231,000 in Cryometrix brand ultra-low temperature freezers. The Cryometrix line of ultra-low temperature freezers uses patented liquid nitrogen cooling technology to achieve cooling rates and system reliability far exceeding current freezer technologies. The Cryometrix ultra-low temperature freezers are available from a 120 liter chest to a front opening unit with 950 liters of capacity.
공시 • Feb 02Reflect Scientific, Inc. Announces New Ultra-Low Temperature Freezer Addition to the CryometrixReflect Scientific, Inc. announced a new ultra-low temperature freezer addition to the Cryometrix product line that can be rapidly deployed in a transportable, self-powered configuration. The new Cryometrix RDC-120 freezer is sized explicitly for storing smaller quantities of vaccines and high-value biologicals. Designed with the same patented liquid nitrogen cooling technology as the very successful larger freezers, the RDC-120 can be installed at a fixed site or configured for entirely self-contained operation. This versatility makes it ideal for field deployment, temporary or permanent cold storage, or a transportable low-temperature storage unit. The internal storage capacity is approximately 120 liters and has a temperature storage range of 0C to -160C. Cooldown from room temperature to -80C takes a short 5 minutes. Return to a set temperature of -80C after door opening is a speedy 2 minutes protecting valuable payloads such as the Pfizer COVID vaccine from damaging temperature swings.
공시 • Jan 14Reflect Scientific Inc Receives Sales Contract for Cryometrix FreezersReflect Scientific, Inc. announced a $416K sales contract for Cryometrix B-90 blast freezers from a prominent pharmaceutical company. A significant $416K order has been placed for Cryometrix B-90 blast freezers destined to ship to the US and the British Isles. The Cryometrix B-90 blast freezer is an ultra-cold refrigeration product that can rapidly cool the payload bay from +20C (68F) to -80C (-130F) in 7 minutes. The freezer technology covered under several patents uses a closed liquid nitrogen system keeping the liquid nitrogen from contact with the payload and personnel. The B-90 freezer is used in the process of creating and storing the newest biopharmaceuticals and mRNA vaccines.
공시 • Dec 16Reflect Scientific Inc. Adds Another Low Temperature Refrigeration Patent Solution to Its Growing Intellectual Property Portfolio, and Business UpdateReflect Scientific, Inc. announced that an additional patent has been granted by United States Patent Office for an ultra-low temperature (-160C) chest freezer based on the proven Cryometrix liquid nitrogen cooling technology. Ultra-low temperature mechanical freezers face unique issues. Lack of temperature uniformity throughout the storage volume can be a problem for both upright and chest freezers. Opening and closing the door creates a large influx of warm air causing an extended temperature recovery time. Reflect Scientific has already addressed this concern for upright freezers with its unique liquid nitrogen based Cryometrix system. A recently issued Reflect Scientific patent now addresses these concerns with a superior chest freezer design. The Cryometrix chest freezer temperature stability and resistance to warm air infiltration during opening provides a very consistent, controlled low temperature environment that can be relied upon for safely storing high value products such as CAR-T therapeutics. This patented technology provides the next level of temperature uniformity and control. The cold chain management of COVID vaccines continues to present challenges in storage and distribution; and believe patented freezer technology could have a favorable and positive impact on the current pandemic and would be a valuable asset for the distribution and storage of the current COVID-19 vaccines that require storage at extremely cold temperatures. On sales front, have several freezer systems scheduled for shipment this year, with a number of other orders anticipated in the first quarter of 2021 from multiple worldwide pharmaceutical companies; are pleased with the level of activity are seeing, and remain optimistic that the Company may realize positive earnings per share for 2020. The Company is presently debt free. In the area of cold chain management, are continuing discussions with a major supplier of air transport containers regarding the integration of liquid nitrogen systems to enable cooling and temperature control of sensitive payloads. Company are still awaiting response from Operation Warp Speed, a FEMA contractor, and other organizations, from who have received inquiries for Cryometrix S-90 cryogenic shipping and storage system. These systems can also serve as a cold (e.g. -80C) storage unit once at destination. do have a large-scale manufacturing capability should these inquires firm up. In terms of the competitive advantages of products, believe the Cryometrix liquid nitrogen freezers offer the following principal benefits versus mechanically driven ULT's or the utilization of dry ice. They can: (i) accommodate a wide range of temperature storage conditions (i.e. anywhere from room temperature to as low as -90C); (ii) have a very rapid temperature recovery from door openings, making it safer, for example, in maintaining COVID vaccines at the desired critical temperature; and (iii) the Cryometrix liquid nitrogen system has a very high operational reliability, keeping potential waste of valuable payloads to essentially zero compared to mechanically driven freezers that can be susceptible to failure. Company do not require dry ice, which has temperature limitations. Dry ice is limited to -78.5C (the current Pfizer vaccine has been reported to require -80C); and dry ice can also present challenges with respect to handling. On the other hand, liquid nitrogen in the Cryometrix system is in a contained environment. Cryometrix freezers typically show higher storage capacity per footprint compared to mechanical freezers, and they have excellent temperature uniformity throughout the payload space with essentially no build-up of ice on payload. The newly granted patent for a “chest” freezer will be a welcome and important addition to Cryometrix freezers.
공시 • Dec 03Reflect Scientific, Inc. Announces A Patent Has Been Granted by the United States Patent Office for an Ultracold Shipping and Storage Container for Transportation by Air That Uses Liquid Nitrogen Technology for CoolingReflect Scientific, Inc. announced a patent has been granted by the United States Patent Office for an ultracold shipping and storage container for transportation by air that uses liquid nitrogen technology for cooling. The large shipping system could carry many thousands of doses of vaccines and utilizes the commercially proven Cryometrix patented cooling and freezing technology that has the flexibility to provide precise temperature control across a wide range of temperatures. The system accommodates payloads ranging from those requiring conventional refrigeration to specialty products such as COVID-19 and related vaccines that may require temperatures as low as -80° centigrade (-112° Fahrenheit). Systems can be configured to provide for short or long duration shipping cycles, making it an ideal choice for cold chain management.
공시 • Oct 13Reflect Scientific, Inc. Introduces Cryometrix Electric Powered Heavy-Duty Trucks for Pollution Free Shipping of COVID-19 VaccinesReflect Scientific, Inc. announced with several companies working towards introducing electric powered heavy-duty trucks, the Cryometrix 53-foot reefer trailer is ideally positioned to complete an all green package that replaces the diesel-powered tractor-trailers that are currently in use for transportation of goods requiring controlled temperatures. The Cryometrix technology offers a reliable, pollution-free system with a flexible wide-ranging temperature setpoint control that can be adjusted to match payload requirements. This single system approach could be an essential consideration when selecting a transportation means for shipping biologics such as COVID-19 vaccines. The Cryometrix CB-40 TRU is a pollution free refrigeration alternative to diesel-powered systems for transport trailers. The CB-40 uses a patented self-contained liquid nitrogen cooling system to achieve consistent temperature control with almost no moving parts, no noise and superior reliability. A closed, self-contained refrigeration system ensures nothing but fresh cold air enters the trailer. The system is a direct replacement for current diesel systems and is easily retrofitted into an existing trailer. Not only is there no diesel engine, there is also no compressor. Fewer moving parts contribute to a significantly reduced maintenance requirement. System weight is comparable to diesel systems. The Cryometrix system was proven in demonstration runs from Salt Lake City to Los Angeles and Denver. A challenging first test -- to maintain refrigeration in a 53-foot trailer filled with perishable goods traveling round trip from Salt Lake City, UT to Los Angeles, CA. The unit performed beyond expectations. The goods were delivered with no loss and no significant problems with the system. The 1323 mile road test proved successful. The second successful test involved the transportation of frozen foodstuffs to Denver. Frozen ravioli, lasagna, corn dogs, and for desert ice cream and popsicles were all loaded into a 53-foot trailer in Salt Lake City. Exactly 525 miles, seven stops and 24 hours later, the trailer, now empty, sat quietly in Denver, still maintaining the temperature at -15 F. This was a tough test for the system as maintaining products frozen at -15 F is challenging, the outside air temperature was varying and there were multiple stops where cargo was unloaded.